Opening Ceremony for the Industrial Hub of Animal Green Bio-Pharmaceuticals Held on March 26

Establishment of Advanced Analysis System for Green Bio Materials

The period required to discover candidate substances for animal pharmaceuticals has been reduced to less than three days thanks to an advanced analysis system utilizing artificial intelligence (AI) and robotics technology. The pace of new drug development in the animal green bio sector is expected to accelerate significantly.


On March 26, the Ministry of Agriculture, Food and Rural Affairs announced at the opening ceremony of the industrial base for animal green bio-pharmaceuticals in Pohang, North Gyeongsang Province, that it had established an advanced analysis system and an industrial hub for animal green bio-pharmaceuticals to support the development of animal pharmaceuticals, a key area in green bio.


A bioreactor, a key piece of equipment for industrializing green bio-pharmaceuticals for animals. Ministry of Agriculture, Food and Rural Affairs

A bioreactor, a key piece of equipment for industrializing green bio-pharmaceuticals for animals. Ministry of Agriculture, Food and Rural Affairs

View original image

Animal pharmaceuticals are developed through multiple stages, from the discovery of candidate substances to efficacy and safety evaluations, clinical trials, and commercialization. In particular, clinical trials are conducted in facilities with strict quality and manufacturing control standards, such as GMP (Good Manufacturing Practice) certified sites. As a result, venture companies with strong technical capabilities but insufficient funding have faced difficulties in the commercialization process. With the establishment of this industrial hub, the Ministry expects that the development environment for related companies will improve, further accelerating the pace of new drug development.


The advanced analysis system is automated equipment that rapidly identifies candidate substances by leveraging AI and robotics technology. Previously, researchers had to conduct repeated experiments to search for candidate substances. With the introduction of this system, the process has become automated, significantly improving both the speed and efficiency of discovery. Accordingly, the period required for discovery, which typically took more than a month, can now be dramatically shortened to within three days.


The industrial base for animal green bio-pharmaceuticals provides equipment for cell culture and for extracting and purifying pharmaceutical materials. Through this, companies can manufacture clinical trial samples from the previously discovered candidate substances. In particular, by introducing a disposable cell culture system, the risk of contamination in cultured cells is reduced, and the production scale can be flexibly adjusted according to corporate demand, maximizing the utility of the equipment.



Jeong Kyungseok, Director General of Food Industry Policy at the Ministry of Agriculture, Food and Rural Affairs, stated, "This support for infrastructure in animal green bio-pharmaceuticals will serve as an opportunity to further enhance the industrial competitiveness of our companies," adding, "We will continue our policy efforts so that promising companies can receive comprehensive support at every stage, from technology development to product commercialization."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing